Vaccine Approval Controversy

Karen shares her perspective on the controversial dynamics surrounding vaccine approvals, particularly focusing on the contracts between the government and pharmaceutical companies. She argues that while Pfizer claimed FDA approval, the implications of emergency use authorization and intellectual property rights create a complex landscape that impacts market competition, especially for Moderna. The discussion highlights the tension between perceived safety and the legal frameworks governing vaccine distribution.